pharmaceutical investing Cyclacel Pharmaceuticals Announces Initiation of Phase 1b/2 Clinical Trial of Sapacitabine With Olaparib in BRCA Mutant Breast Cancer
Sun Summit Commences Drilling and Provides Exploration Update from the JD Project in BC's Toodoggone District
